New research has highlighted the benefits of yoga and walking for cutting the risk of cancer spreading or returning post-treatment – but we can all benefit from introducing these low-impact ...
Studies show that yoga can help cancer patients live a longer life. Yoga can also help reduce inflammation in the body. What are the other positive aspects of yoga? Molly Gambhir tells you more.
Follow a balanced diet that is rich in fruits, vegetables, whole grains, and lean proteins. Cut down on consumption of sugary ...
To practice these yoga asanas, simply find a quiet and comfortable place to sit or lie down on a yoga mat. It is also known as crocodile pose, this is good for asthma, reduces the risk of breast ...
Short bursts of vigorous daily activity that leave you out of breath could cut the risk of cancer by nearly 20 per cent, scientists have said. A new study found four and a half minutes of vigorous ...
Fresh evidence that aspirin is a cancerfighting wonderdrug has emerged as a study suggests it could cut the risk of mouth, throat and oesophagus tumours by two-thirds. Scientists have already ...
This article is based on reporting that features expert sources. How Yoga Can Support Heart Health We've been told for years that exercise is good for us and we need to get more of it in order to ...
Eating tomato sauce twice a week could reduce the risk of men developing prostate cancer by up to a third, according to new research. American experts, who carried out one of the biggest studies ...
Statins Can Cut Colorectal Cancer Risk in Ulcerative Colitis Patients, Study Finds Claire Bugos September 20, 2023 at 1:29 PM ...
Can taking aspirin or ibuprofen reduce your risk of getting breast cancer? One of the largest studies of its kind suggests that the answer might be yes. In the past, researchers have flip-flopped ...
From when we're young, we were always told to eat our vegetables because they are good for us - but it's only when we're adults we start to understand their true health benefits. And it turns out ...
TUESDAY, July 24 (HealthDay News) -- Despite concerns over cardiovascular side effects, a U.S. Food and Drug Administration panel on Tuesday recommended the osteoporosis drug Evista (raloxifene ...
